Background: Treatment of oncogene-addicted non-small cell lung cancer (NSCLC) has been changed by the advent of tyrosine kinase inhibitors (TKIs). Albeit great benefits are achieved with target therapies, resistance invariably occurs and recourse to alternative treatments is unavoidable. Immune chec...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!